An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836.
Clinical trial NCT00996268 · COMPLETED
Trial details
- NCT number
- NCT00996268
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-15
- Primary completion
- 2010-01-04
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.